Main > ONCOLOGY (**) > Brain Cancer>GBM *** > Treatment > USA. A. BioSimilar BevacizuMAb
USA. A. BioSimilar BevacizuMAb's subsections
(*) USA Approval Date: 2017. 09.14
Company
PR Web-Site
TradeMark
TradeMark Web-Site
USA. A. BioSimilar BevacizuMAb's products
This section has no products